Clinical Report: DEWS III: Revised Definition; 1 Questionnaire; and More

Overview

The DEWS III report introduces a revised definition of dry eye disease (DED) and a standardized questionnaire, the Ocular Surface Disease Index-6 (OSDI-6), to enhance symptom assessment. It expands the classification of DED etiologies to nine drivers across three subcategories, improving management strategies for clinicians.

Background

Dry eye disease is a prevalent condition affecting millions globally, often leading to significant discomfort and impaired quality of life. Accurate diagnosis and effective management are crucial, as DED presents with varying severity and underlying causes. The DEWS III report aims to provide updated guidelines and tools for clinicians to better address this multifactorial disease.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

• DEWS III defines dry eye as a multifactorial, symptomatic disease with loss of homeostasis in the tear film and ocular surface.
• The OSDI-6 questionnaire standardizes symptom assessment, reducing variability from multiple tools.
• DEWS III identifies nine etiologic drivers of DED, categorized into tear film, eyelids, and ocular surface.
• The prescribing algorithm has been updated to reflect new treatment options for DED subtypes.
• First-line treatments focus on replenishing and conserving the tear film, with specific attention to meibomian gland dysfunction.

Clinical Implications

Clinicians should adopt the OSDI-6 questionnaire for consistent symptom evaluation in dry eye patients. Understanding the nine identified etiologic drivers will aid in tailoring treatment strategies to individual patient needs, enhancing overall management of DED.

Conclusion

The DEWS III report represents a significant advancement in the understanding and management of dry eye disease, providing clinicians with essential tools and updated classifications to improve patient care.

References

1. TFOS DEWS III: Management and Therapy - ScienceDirect, 2025 -- DEWS III Report
2. TFOS DEWS III: Executive Summary - PubMed, 2025 -- DEWS III Overview
3. Ophthalmology Management — Coding & Reimbursement, 2023 -- Coding and Reimbursement
4. Optometric Management — Viewpoint: The DEWS Smartphone, 2025 -- DEWS Smartphone Comparison
5. Optometric Management — CLINICAL: Dry Eye Recommendations, 2021 -- Treatment Protocols
6. Optometric Management — CLINICAL: Dry Eye, 2021 -- Clinical Management
7. Optometric Management — CLINICAL: Dry Eye Recommendations
8. TFOS DEWS III: Executive Summary - PubMed
9. TFOS DEWS III: Management and Therapy - ScienceDirect